Abstract
Effective treatment of penile carcinoma incorporates three modalities: surgery, radiation and chemotherapy. Surgery alone may offer a high cure rate in early stages of the disease. In certain patients radiation therapy may be utilized to eradicate the tumor and allow organ preservation. For patients with locally advanced disease, multi-modality approaches incorporating adjuvant or neoadjuvant chemotherapy and radiation therapy need to be studied. This approach may confer a survival benefit to a group that would otherwise have a poor prognosis. Finally, in the setting of metastatic disease, less toxic and more effective combination chemotherapy are sought. Novel targeted therapies that have been successful in squamous cell carcinoma at other sites must also be studied in this disease. We believe that multi-institutional trials should be designed in order to obtain prospective benchmark data from which to make valid comparisons of outcome.
Original language | English (US) |
---|---|
Pages (from-to) | 431-438 |
Number of pages | 8 |
Journal | Urologic Oncology: Seminars and Original Investigations |
Volume | 21 |
Issue number | 6 |
DOIs | |
State | Published - Nov 2003 |
Keywords
- Chemotherapy
- Novel agents
- Penile cancer
- Radiation therapy
ASJC Scopus subject areas
- Oncology
- Urology